Skip to main content
Premium Trial:

Request an Annual Quote

The War Goes On

The Science Business Blog at Forbes looks into what it dubs the “gene machine wars.” There, Matthew Herper points out that just weeks after Illumina announced that its HiSeq 2000 could sequence a human genome for about $10,000, that Life Technologies said its SOLiD 4 that could do it for $6,000. Herper says that Illumina won’t lose its place at the top. “Although the news is good for Life and will keep it in the game as the price of decoding the genetic code continues to drop, the specs of this new machine don't seem good enough to upset Illumina's place as the first choice of geneticists,” he writes.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.